Piper Sandler raises Driven Brands stock price target on financials By Investing.com

Driven Brands reported Q4 2025 revenue of $460.1 million, up 7.7% year over year, with adjusted diluted EPS of $0.34 and fiscal 2026 revenue guidance of $1.95 billion to $2.05 billion. However, management lowered 2026 EBITDA outlook below expectations due to about $40 million of one-time restatement-related expenses and early 2026 comp moderation at Take 5. Piper Sandler raised its price target to $13 from $11, but the stock already trades at $13.23, near that target.

Analysis

The core issue here is not the accounting restatement itself; it is that the market is now re-rating DRVN as a governance-quality story rather than a pure unit-growth story. That usually compresses the multiple for several quarters, because investors demand proof that reported EBITDA is now “clean” before paying for faster growth. The fact that Take 5 is moderating at the same time is important: when the growth engine slows, the market loses the ability to look through one-time charges and will instead anchor on execution risk.

The second-order effect is competitive. If DRVN is forced to spend management attention, audit bandwidth, and cash on remediation, it likely loses some operational agility versus VVV, which appears better positioned to capitalize on any softness in quick-lube demand. But the bigger point is that a restatement episode often changes customer, franchisee, and vendor confidence more than Street perception; those issues can show up with a lag over the next 2-3 quarters via slower openings, less favorable terms, or weaker same-store conversion.

The contrarian setup is that the stock may already be near a “damaged goods” equilibrium: if the market is pricing in permanent discounting, incremental bad news may matter less than a credible few-quarter clean-up path. The risk to the downside is that 2026 guidance revisions become a recurring event rather than a one-off, especially if the one-time costs are followed by operational drag or further control remediation. On the upside, a clean audit cycle and stabilization in Take 5 comps could force a sharp multiple rebound, but that likely requires 6-9 months of consistent delivery rather than a quick reset.

Key Decisions for Investors

• Short DRVN on any bounce toward the analyst target band; use a 3-6 month horizon with a tight stop above the post-restatement peak, as the setup is vulnerable to another guidance reset if remediation costs or growth deceleration persist.
• Pair trade: long VVV / short DRVN for the next 1-2 quarters. The relative-value case is that quick-lube exposure with cleaner governance should capture the same category demand with less multiple compression risk.
• Avoid buying DRVN calls into the next earnings cycle unless there is explicit evidence of restored accounting controls; optionality is poor here because the stock needs multiple clean quarters, not a single beat, to re-rate.
• If forced long, wait for a post-earnings washout and only buy after management quantifies no further restatement risk. Risk/reward improves materially if the stock trades below the implied fair-value gap and the market capitulates on governance concerns.